ADMA Biologics, Inc.ADMANASDAQ
Loading
Operating cash flow minus capital expenditures
Percentile
P93
Near historical high
vs 2Y Ago
7.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $27.82M | -74.7% |
| 2024 | $110.10M | +2782.9% |
| 2023 | $3.82M | +105.2% |
| 2022 | $-73.42M | +41.7% |
| 2021 | $-125.88M | -9.7% |
| 2020 | $-114.73M | -43.4% |
| 2019 | $-80.01M | -23.5% |
| 2018 | $-64.77M | -62.1% |
| 2017 | $-39.95M | -117.8% |
| 2016 | $-18.34M | - |